![](/img/cover-not-exists.png)
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Kolstad, Arne, Illidge, Tim, Bolstad, Nils, Spetalen, Signe, Madsbu, Ulf, Stokke, Caroline, Blakkisrud, Johan, Løndalen, Ayca, O'Rourke, Noelle, Beasley, Matthew, Jurczak, Wojciech, Fagerli, Unn-MereVolume:
4
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2020002583
Date:
September, 2020
File:
PDF, 1.28 MB
2020